ATE154879T1 - Zusammensetzung und verfahren zur behandlung von akne vulgaris und verzögerung des alterns - Google Patents

Zusammensetzung und verfahren zur behandlung von akne vulgaris und verzögerung des alterns

Info

Publication number
ATE154879T1
ATE154879T1 AT91906989T AT91906989T ATE154879T1 AT E154879 T1 ATE154879 T1 AT E154879T1 AT 91906989 T AT91906989 T AT 91906989T AT 91906989 T AT91906989 T AT 91906989T AT E154879 T1 ATE154879 T1 AT E154879T1
Authority
AT
Austria
Prior art keywords
acne vulgaris
composition
treating acne
delaying aging
derivative
Prior art date
Application number
AT91906989T
Other languages
English (en)
Inventor
Lit-Hung Leung
Original Assignee
Leung Lit Hung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leung Lit Hung filed Critical Leung Lit Hung
Application granted granted Critical
Publication of ATE154879T1 publication Critical patent/ATE154879T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT91906989T 1990-03-27 1991-03-27 Zusammensetzung und verfahren zur behandlung von akne vulgaris und verzögerung des alterns ATE154879T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909006785A GB9006785D0 (en) 1990-03-27 1990-03-27 Composition and methods for treatment of acne vulgaris and retardation of ageing

Publications (1)

Publication Number Publication Date
ATE154879T1 true ATE154879T1 (de) 1997-07-15

Family

ID=10673309

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91906989T ATE154879T1 (de) 1990-03-27 1991-03-27 Zusammensetzung und verfahren zur behandlung von akne vulgaris und verzögerung des alterns

Country Status (12)

Country Link
US (2) US5459153A (de)
EP (1) EP0527757B1 (de)
JP (1) JP3409127B2 (de)
AT (1) ATE154879T1 (de)
AU (1) AU654812B2 (de)
CA (1) CA2078670C (de)
DE (1) DE69126703T2 (de)
DK (1) DK0527757T3 (de)
ES (1) ES2106076T3 (de)
GB (1) GB9006785D0 (de)
GR (1) GR3024544T3 (de)
WO (1) WO1991014431A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364885A (en) * 1992-11-13 1994-11-15 Ahluwalia Gurpreet S Reduction of hair growth
DE4328871A1 (de) * 1993-08-27 1995-03-02 Beiersdorf Ag Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis
US5616617A (en) * 1995-11-27 1997-04-01 Van Moerkerken; Arthur Face pimples prevention method and compositions
US5833998A (en) * 1995-11-06 1998-11-10 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
US6238678B1 (en) 1995-11-06 2001-05-29 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
US5939082A (en) * 1995-11-06 1999-08-17 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
WO1997039734A1 (en) * 1996-04-23 1997-10-30 The Procter & Gamble Company Methods of regulating skin condition with centella asiatica extract
US5968528A (en) * 1997-05-23 1999-10-19 The Procter & Gamble Company Skin care compositions
USH2013H1 (en) 1997-05-23 2002-02-05 The Procter & Gamble Company Skin care compositions
EP1063967B1 (de) 1998-03-16 2004-02-11 The Procter & Gamble Company Zusammensetzung zur regulierung des hauterscheinungsbildes
FR2780888B1 (fr) * 1998-07-09 2000-10-13 Benac Lotion nettoyante et traitante destinee au traitement des comedons
AU5686799A (en) * 1998-08-27 2000-03-21 Procter & Gamble Company, The Methods of reducing the irritation associated with vitamin b3 compositions
WO2000032179A2 (en) * 1998-12-01 2000-06-08 University Of Kentucky Research Foundation Use of nicotonic acid derivatives for the treatment of dna damage in skin cells
US6444647B1 (en) 1999-04-19 2002-09-03 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US6979468B1 (en) 2002-12-06 2005-12-27 Sirius Laboratories Oral composition and method for the treatment of inflammatory cutaneous disorders
US20050048012A1 (en) * 2003-08-26 2005-03-03 Roland Jermann Use of biotin or a biotin derivative for skin lightening purposes and for the treatment of senile lentigines
JP5338030B2 (ja) * 2007-01-31 2013-11-13 大正製薬株式会社 アダパレン含有外用剤組成物
US20100068334A1 (en) * 2008-09-12 2010-03-18 Damon Randolph Race Medicinal Food and Beverage Compositions and Related Methods for Managing Acne in Humans

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
US4885157A (en) * 1987-02-13 1989-12-05 Fiaschetti Mary G Dermal cosmetic composition and applications therefor
LU87145A1 (fr) * 1988-02-26 1989-09-20 Oreal Methode pour ameliorer l'aspect esthetique de la peau a l'aide de melanges polyvitaminiques
US4857321A (en) * 1988-08-26 1989-08-15 Thomas William C Skin ointment

Also Published As

Publication number Publication date
AU654812B2 (en) 1994-11-24
GB9006785D0 (en) 1990-05-23
CA2078670C (en) 2003-02-11
GR3024544T3 (en) 1997-12-31
DK0527757T3 (da) 1998-01-19
EP0527757B1 (de) 1997-07-02
HK1001185A1 (en) 1998-05-29
DE69126703D1 (de) 1997-08-07
WO1991014431A1 (en) 1991-10-03
JP3409127B2 (ja) 2003-05-26
CA2078670A1 (en) 1991-09-28
DE69126703T2 (de) 1998-02-05
ES2106076T3 (es) 1997-11-01
US5519039A (en) 1996-05-21
EP0527757A1 (de) 1993-02-24
US5459153A (en) 1995-10-17
JPH05505819A (ja) 1993-08-26
AU7565891A (en) 1991-10-21

Similar Documents

Publication Publication Date Title
DE69126703D1 (de) Zusammensetzung und verfahren zur behandlung von akne vulgaris und verzögerung des alterns
NZ337211A (en) Method of treating inflammatory, HIV diseases by using peptidyl boronic acid ester and acid compounds as proteasome inhibitors
MY110734A (en) Improvements in or relating to dioic acids.
TW225532B (de)
ATE121939T1 (de) Ascorbinsäure-tocopheryl-phosphatdiester zur hemmung der maillard-reaktion.
GEP20012413B (en) Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
AU587054B2 (en) Novel pharmaceutical compositions intended to the treatment of neuropathies and insuring the nervous regeneration
GR3031917T3 (en) Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors
WO1999012951A8 (en) Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
WO2004007676A3 (en) Combination therapy for the treatment of neoplasms
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
HUT70979A (en) Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine
CA2100066A1 (en) Michellamines useful as antiviral agents, composition and method of treatment
NO943126L (no) 3-alkyloksy-, aryloksy- eller arylalkyloksybenzo-[bÅtiofen-2-karboksamider som hemmere av celleadhesjon
DE69822626D1 (de) Verwendung eines nitroxids oder seiner prodrugs zur prophylaktischen und therapeutischen behandlung von krebs
MY104521A (en) Treatment of depression.
DK1025101T3 (da) Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet
DE3485282D1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
AU2629500A (en) A method for treating patients with acne by administering a cyclic gmp pde inhibitor
DE69331237D1 (de) Antiatherosclerotische mittel
MX9706404A (es) Metodo para tratar deplecion de adenosina.
UA30659A (uk) Спосіб купіровання опіатної залежності

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee